AVITA Medical, Inc.RCELNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +43.25% | +29.67% | +66.73% | +21.21% | -12.71% |
| Gross Profit Growth | +41.83% | +30.06% | +63.50% | +14.25% | -15.17% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.29% | +2.60% | +2.40% | +2.36% | +9.27% |
| Weighted Average Shares Diluted Growth | +2.29% | +2.60% | +2.40% | +2.36% | +9.27% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +69.74% | +51.03% | +29.69% | +16.41% | -31.95% |
| Inventory Growth | +42.31% | +29.90% | +17.07% | +12.33% | +16.23% |
| Asset Growth | +0.05% | -28.60% | -28.57% | -33.81% | -21.37% |
| Book Value per Share Growth | -81.02% | -91.06% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +1559.73% | +8.43% | -1.48% | -1.11% | -1.87% |
| R&D Expense Growth | +23.53% | -28.31% | +20.99% | +4.71% | -30.95% |
| SG&A Expenses Growth | +48.50% | +18.18% | -1.75% | -11.93% | -22.05% |